US20050033070A1 - Synthesis of ester linked long chain alkyl moieties - Google Patents

Synthesis of ester linked long chain alkyl moieties Download PDF

Info

Publication number
US20050033070A1
US20050033070A1 US10/488,028 US48802804A US2005033070A1 US 20050033070 A1 US20050033070 A1 US 20050033070A1 US 48802804 A US48802804 A US 48802804A US 2005033070 A1 US2005033070 A1 US 2005033070A1
Authority
US
United States
Prior art keywords
cetyl
aromatic hydrocarbon
mixture
acid
myristate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/488,028
Other versions
US7411079B2 (en
Inventor
Diane Cadwallader
Parag Jhaveri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lypanosys Pte Ltd
Original Assignee
Meracol Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meracol Corp Ltd filed Critical Meracol Corp Ltd
Publication of US20050033070A1 publication Critical patent/US20050033070A1/en
Assigned to MERACOL CORPORATION LIMITED reassignment MERACOL CORPORATION LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CADWALLADER, DIANNE
Assigned to MERACOL CORPORATION LIMITED reassignment MERACOL CORPORATION LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JHAVERI, PARAG
Application granted granted Critical
Publication of US7411079B2 publication Critical patent/US7411079B2/en
Assigned to MERACOL INVESTMENTS LIMITED reassignment MERACOL INVESTMENTS LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MERACOL CORPORATION LIMITED
Assigned to LYPANOSYS LIMITED reassignment LYPANOSYS LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MERACOL INVESTMENTS LIMITED
Assigned to LYPANOSYS PTE LIMITED reassignment LYPANOSYS PTE LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LYPANOSYS LIMITED
Adjusted expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/003Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols

Definitions

  • the present invention relates to synthesis of ester linked long chain alkyl moieties. More particularly the present invention comprises an improved synthesis of C12+C14 cetyl ester and to products so synthesised.
  • Cetyl myristate and cetyl palmitate are useful in the formulation of cosmetics and pharmaceuticals. More particularly, this invention in the synthesis of said cetyl myristate with required palmitate, relates more specially to improved synthesis yields as well as more efficient removal of impurities in the process.
  • esters, cetyl myristate and cetyl palmitate are each currently marketed for use in cosmetics and pharmaceuticals.
  • Cetyl myristate has been produced by an acid catalysed reaction of myristic acid with cetyl alcohol. Cetyl pahmitate likewise has been produced by an acid catalysed reaction of palmitic acid with cetyl alcohol. Because of the purity requirements of the cosmetic and pharmaceutical industries each product so synthesised requires extensive and intensive purification procedures.
  • the present invention consists in a process for preparing a mixture of cetyl myristate and cetyl palmitate which comprises,
  • said elevated temperature(s) are from 65° C. to 140° C.
  • the ratios of the reactants is substantially stoichiometric.
  • the acid catalyst is one that will predominate (preferably almost exclusively) in an aqueous fraction rather than that of said aromatic hydrocarbon.
  • said catalyst is phosphoric acid (preferably 85% phosphoric acid).
  • aqueous fraction from which the aromatic hydrocarbon fraction is separated prior to recovering the cetyl myristate & cetyl palmitate from the aromatic hydrocarbon fraction.
  • substantially all of the catalyst is retained in the aqueous fraction.
  • said aromatic hydrocarbon is of the benzene series and has from six to nine carbon atoms.
  • the aromatic hydrocarbon is toluene or xylene (or a mixture thereof).
  • cetyl myristate comprises from about 50 to about 98% w/w of the mixture.
  • the recovering of cetyl myristate and cetyl palmitate is by crystallisation and recovery from the aromatic hydrocarbon.
  • our invention comprises a process for preparing a mixture of cetyl myristate and cetyl palmitate, this process includes reacting cetyl alcohol with fatty acids selected from group of C10-C18. admixed with an aromatic hydrocarbon containing from 6 to 8 carbon atoms of the benzene series in the presence of an phosphoric acid at an elevated temperature with agitation for several hours i.e. 8-45 hours.
  • the desired product is recovered from the aromatic liquid hydrocarbon.
  • One preferred recovering procedure is crystallization and filtration.
  • the aromatic liquid can be employed to continuously extract ester from the reaction mixture as the reaction is in progress.
  • One of the most preferred aspects of the present invention resides in the employment of aromatic non-miscible liquid hydrocarbon.
  • a solvent such as toluene or xylene is superior to any other solvent suggested by the prior art.
  • the invention consists in a mixture of cetyl myristate and cetyl palmitate produced by a process as previously defined.
  • the invention consists in the use of such a mixture in the treatment of inflammatory ailment in a mammal or in a process to produce an oral pharmaceutical composition useful in the treatment of inflammatory ailments.
  • one such ailment is asthma.
  • cetyl myristate comprises from about 50 to about 98% w/w of the mixture.
  • the present invention consists in an oral composition for treating inflammatory ailments comprising or including both cetyl myristate and cetyl palmitate.
  • the composition comprises from 50 to 98% w/w of cetyl myristate with respect to the total weight of cetyl myristate and cetyl palmitate.
  • the ailment is asthma.
  • Myristic acid/palmitic acid 200 cc. of 85% phosphoric acid and 1800 ml. of hexane were mixed, heated to reflux and then 251 grams of cetyl alcohol added in 30 min. The mixture was refluxed further for 8 hours. Then the hot mixture consisted of a muddy acid layer and a opaque solvent layer which could not be separated by decantation or filtration. The mixture was further diluted with three volumes of hexane causing the slushy hexane layer to further soften enough to be separated from aqueous layer. The hexane layer was then cooled to bring about crystallization of fatty ester. The weight of cetyl myristate isolated was 294 grams which had a melting point of 54-59° C. The conversion, based on the cetyl alcohol used, was 63.71%.
  • Myristic acid/palmitic acid, 400 cc. of 85% phosphoric acid were mixed, heated to 95 C., and 251 grams of cetyl alcohol was added over a period of 30 minutes. The mixture further heated in vacuum and then on cooling.
  • the reaction mixture, which contained a finely divided white solid, was diluted to 3000 ml. with water cooled to 25 C. and filtered. The white product was treated with hot water, and the mixture filtered hot to remove any alcohol.
  • the unreacted fatty acid was present in a large quantity. The reaction was not complete.
  • the filtrate was cooled to bring about crystallization of cetyl myristate which was isolated by filtration.
  • the weight of cetyl myristate isolated was 436 grams which had a melting point of 54-58° C.
  • the percentage conversion based on the cetyl alcohol employed was 92.3 percent.
  • Myristic acid/palmitic acid 250 grams of 85% phosphoric acid and 1000 cc. of xylene were mixed in a three neck flask provided with thermometer, agitator and reflux condenser. The temperature was increased to 105 with good agitation and 55 grams of cetyl alcohol was introduced over a one-hour period. After the reaction the supernatant xylene layer was drawn off, and the lower phosphoric acid layer was preserved for use in the following run.
  • the solvent which is employed in accordance with our invention is most advantageously toluene or xylene although other aromatic hydrocarbons of the benzene series containing from six to eight or nine carbon atoms can be employed.
  • the catalyst employed in accordance with our invention is most advantageously phosphoric acid; however, other acid catalysts can be employed.
  • the use of 85% phosphoric acid is advantageously employed in the various examples given; however, equivalent quantities of other strengths of phosphoric acid can also be employed.
  • the elevated temperature employed in accordance with our process is most advantageously that at which reflux conditions exist. With proper stirring, temperatures which are higher or lower than that by reflux can also be employed. (temperature of from about 65 to about 140° C. can be advantageously employed)
  • temperatures which are higher or lower than that by reflux can also be employed. (temperature of from about 65 to about 140° C. can be advantageously employed)
  • Myristic acid/palmitic acid, 400 cc. of 85% phosphoric acid and 2400 cc. of xylene were mixed in a three neck flask provided with a thermometer, agitator and reflux condenser. The temperature was raised to 105° C. with good agitation and 251 grams of cetyl alcohol was introduced with good agitation over a 1-hour period. The mixture reflux for 36 hour. Next, the supernatant xylene layer was drawn off, and the lower phosphoric acid layer was preserved for use in a subsequent run. The xylene layer on cooling deposited a crystalline solid which weighed 438 grams. This crude material was substantially cetyl myristate and was purified by recrystallization from hot xylene so as to yield pure cetyl myristate having a melting point of 54-56° C.
  • the water which is formed by the employment of cetyl alcohol in the course of the reaction as in Example 2 dilutes the reaction mixture but can be readily removed by azeotropic distillation of the reaction mixture.

Abstract

A process for preparing a mixture of cetyl myristate and cetyl palmitate comprising reacting both myristic and palmitic acid with cetyl alcohol with an acid catalyst and one aromatic hydrocarbon at an elevated temperature and recovering from the aromatic hydrocarbon fraction the cetyl myristate and cetyl palmitate.

Description

    BACKGROUND
  • The present invention relates to synthesis of ester linked long chain alkyl moieties. More particularly the present invention comprises an improved synthesis of C12+C14 cetyl ester and to products so synthesised.
  • Cetyl myristate and cetyl palmitate are useful in the formulation of cosmetics and pharmaceuticals. More particularly, this invention in the synthesis of said cetyl myristate with required palmitate, relates more specially to improved synthesis yields as well as more efficient removal of impurities in the process.
  • The esters, cetyl myristate and cetyl palmitate are each currently marketed for use in cosmetics and pharmaceuticals.
  • Cetyl myristate has been produced by an acid catalysed reaction of myristic acid with cetyl alcohol. Cetyl pahmitate likewise has been produced by an acid catalysed reaction of palmitic acid with cetyl alcohol. Because of the purity requirements of the cosmetic and pharmaceutical industries each product so synthesised requires extensive and intensive purification procedures.
  • DESCRIPTION OF THE INVENTION
  • In one aspect the present invention consists in a process for preparing a mixture of cetyl myristate and cetyl palmitate which comprises,
      • (I) at elevated temperature(s) reacting both myristic acid and palmitic acid with cetyl alcohol in the presence of at least one acid catalyst and at least one aromatic hydrocarbon, and
      • (ii) recovering from the aromatic hydrocarbon fraction the cetyl myristate and cetyl palmitate.
  • Preferably said elevated temperature(s) are from 65° C. to 140° C.
  • Preferably the ratios of the reactants is substantially stoichiometric.
  • Preferably the acid catalyst is one that will predominate (preferably almost exclusively) in an aqueous fraction rather than that of said aromatic hydrocarbon.
  • Preferably said catalyst is phosphoric acid (preferably 85% phosphoric acid).
  • Preferably there is an aqueous fraction from which the aromatic hydrocarbon fraction is separated prior to recovering the cetyl myristate & cetyl palmitate from the aromatic hydrocarbon fraction.
  • Preferably substantially all of the catalyst is retained in the aqueous fraction.
  • Preferably said aromatic hydrocarbon is of the benzene series and has from six to nine carbon atoms.
  • Preferably the aromatic hydrocarbon is toluene or xylene (or a mixture thereof).
  • Preferably the cetyl myristate comprises from about 50 to about 98% w/w of the mixture.
  • Preferably the recovering of cetyl myristate and cetyl palmitate is by crystallisation and recovery from the aromatic hydrocarbon.
  • In another aspect our invention comprises a process for preparing a mixture of cetyl myristate and cetyl palmitate, this process includes reacting cetyl alcohol with fatty acids selected from group of C10-C18. admixed with an aromatic hydrocarbon containing from 6 to 8 carbon atoms of the benzene series in the presence of an phosphoric acid at an elevated temperature with agitation for several hours i.e. 8-45 hours. Preferably after the reaction is complete, the desired product is recovered from the aromatic liquid hydrocarbon. One preferred recovering procedure is crystallization and filtration. Alternatively, in another preferred procedure the aromatic liquid can be employed to continuously extract ester from the reaction mixture as the reaction is in progress.
  • One of the most preferred aspects of the present invention resides in the employment of aromatic non-miscible liquid hydrocarbon. The use of a solvent such as toluene or xylene is superior to any other solvent suggested by the prior art.
  • In still another aspect the invention consists in a mixture of cetyl myristate and cetyl palmitate produced by a process as previously defined.
  • In yet another aspect the invention consists in the use of such a mixture in the treatment of inflammatory ailment in a mammal or in a process to produce an oral pharmaceutical composition useful in the treatment of inflammatory ailments.
  • Preferably one such ailment is asthma.
  • Preferably the cetyl myristate comprises from about 50 to about 98% w/w of the mixture.
  • In still a further aspect the present invention consists in an oral composition for treating inflammatory ailments comprising or including both cetyl myristate and cetyl palmitate.
  • Preferably the composition comprises from 50 to 98% w/w of cetyl myristate with respect to the total weight of cetyl myristate and cetyl palmitate. Preferably the ailment is asthma.
  • Experiment A.—Hexane Solvent
  • Myristic acid/palmitic acid, 200 cc. of 85% phosphoric acid and 1800 ml. of hexane were mixed, heated to reflux and then 251 grams of cetyl alcohol added in 30 min. The mixture was refluxed further for 8 hours. Then the hot mixture consisted of a muddy acid layer and a opaque solvent layer which could not be separated by decantation or filtration. The mixture was further diluted with three volumes of hexane causing the slushy hexane layer to further soften enough to be separated from aqueous layer. The hexane layer was then cooled to bring about crystallization of fatty ester. The weight of cetyl myristate isolated was 294 grams which had a melting point of 54-59° C. The conversion, based on the cetyl alcohol used, was 63.71%.
  • Experiment B.—Heptane Solvent
  • Myristic acid/palmitic acid, 200 cc. of phosphoric acid, and 1800 ml. of heptane were mixed, heated to reflux and then 251 grams of cetyl alcohol refluxed further for 18 hours and separated as in example A. On crystallization, the cetyl myristate obtained was much darker in colour then in Experiment-A.
  • It is evident that this process as exemplified by Experiment B is even less satisfactory than that set forth in Experiment-A.
  • Experiment C.—Alkylation in Absence of a Solvent
  • Myristic acid/palmitic acid, 400 cc. of 85% phosphoric acid were mixed, heated to 95 C., and 251 grams of cetyl alcohol was added over a period of 30 minutes. The mixture further heated in vacuum and then on cooling. The reaction mixture, which contained a finely divided white solid, was diluted to 3000 ml. with water cooled to 25 C. and filtered. The white product was treated with hot water, and the mixture filtered hot to remove any alcohol.
  • The unreacted fatty acid was present in a large quantity. The reaction was not complete.
  • It is quite evident that the entire absence of a solvent in the process results in the complete failure to produce any substantial quantity of said ester.
  • The following example serves to illustrate the process of our invention in a manner as nearly identical as possible to the process of experiment A. In each of Example 1 and Experiment A, the cetyl myristate was filtered from two liters of Toluene. It is evident that the process employing toluene is far superior:
  • EXAMPLE 1 Toluene Solvent
  • 1800 cc. of toluene, myristic acid/palmitic acid and 400 cc. of 85% phosphoric acid were mixed, heated to 92° C. and 251 grams of cetyl alcohol was introduced over a 30-minute period. When the addition was complete, the reaction mixture was further refluxed for 38 hours. The hot reaction mixture was a two phase system consisting of a toluene layer and an aqueous phosphoric acid layer. No solid material was present. The hot toluene layer was separated and mixed with charcoal to remove the undesired colouring matter.
  • The filtrate was cooled to bring about crystallization of cetyl myristate which was isolated by filtration. The weight of cetyl myristate isolated was 436 grams which had a melting point of 54-58° C. The percentage conversion based on the cetyl alcohol employed was 92.3 percent.
  • The following example serves to illustrate the employment of xylene as the solvent, otherwise similar to Example 1 given above:
  • EXAMPLE 2 Xylene Solvent
  • Myristic acid/palmitic acid, 250 grams of 85% phosphoric acid and 1000 cc. of xylene were mixed in a three neck flask provided with thermometer, agitator and reflux condenser. The temperature was increased to 105 with good agitation and 55 grams of cetyl alcohol was introduced over a one-hour period. After the reaction the supernatant xylene layer was drawn off, and the lower phosphoric acid layer was preserved for use in the following run.
  • The xylene layer on cooling deposited a crystalline solid which weighed 154 gms. This material consisted of cetyl myristate and any unreacted fatty acid. The crude product was easily purified by recrystallization from hot xylene to yield pure cetyl myristate M.P.=54-56° C.
  • The process of our invention as exemplified by examples 1 and 2 involves the reaction of approximately equimolecular proportions of fatty acid and cetyl alcohol in order to accomplish the most advantageous results. However, higher and lower proportions within the vicinity of ratio of 1:1 can be employed.
  • The solvent which is employed in accordance with our invention is most advantageously toluene or xylene although other aromatic hydrocarbons of the benzene series containing from six to eight or nine carbon atoms can be employed. The catalyst employed in accordance with our invention is most advantageously phosphoric acid; however, other acid catalysts can be employed. The use of 85% phosphoric acid is advantageously employed in the various examples given; however, equivalent quantities of other strengths of phosphoric acid can also be employed.
  • The elevated temperature employed in accordance with our process is most advantageously that at which reflux conditions exist. With proper stirring, temperatures which are higher or lower than that by reflux can also be employed. (temperature of from about 65 to about 140° C. can be advantageously employed) The following example will serve to illustrate this aspect of our invention:
  • EXAMPLE 3 Xylene Solvent
  • Myristic acid/palmitic acid, 400 cc. of 85% phosphoric acid and 2400 cc. of xylene were mixed in a three neck flask provided with a thermometer, agitator and reflux condenser. The temperature was raised to 105° C. with good agitation and 251 grams of cetyl alcohol was introduced with good agitation over a 1-hour period. The mixture reflux for 36 hour. Next, the supernatant xylene layer was drawn off, and the lower phosphoric acid layer was preserved for use in a subsequent run. The xylene layer on cooling deposited a crystalline solid which weighed 438 grams. This crude material was substantially cetyl myristate and was purified by recrystallization from hot xylene so as to yield pure cetyl myristate having a melting point of 54-56° C.
  • The water which is formed by the employment of cetyl alcohol in the course of the reaction as in Example 2 dilutes the reaction mixture but can be readily removed by azeotropic distillation of the reaction mixture.
  • In addition to the procedure illustrated by Examples 1,2 and 3, a successful batch process can be advantageously employed for preparing cetyl myristate with adequate palmitate which comprises,
      • (1) admixing under reflux conditions about one mole proportion of fatty acid from about 1 to about 5 times the same weight of phosphoric acid and from about 1 to about 2 times the same weight of an aromatic hydrocarbon containing from 6 to 8 carbon atoms,
      • (2) maintaining this admixture at its boiling point under good agitation and gradually introducing into this admixture about one mole proportion cetyl alcohol while substantially concurrently removing water by azeotropic distillation,
      • (3) thereafter separating while hot the layer containing the principal part of IC aromatic hydrocarbon from the layer containing the phosphoric acid,
      • (4) then cooling this layer whereby a product consisting primarily of cetyl myristate separates as crystals, and
      • (5) admixing under refluxed condition for 38 hours.

Claims (20)

1. A process for preparing a mixture of cetyl myristate and cetyl palmitate which comprises, (i) at elevated temperature(s) reacting both myristic acid and palmitic acid with cetyl alcohol in the presence of at least one acid catalyst and at least one aromatic hydrocarbon, and (ii) recovering from the aromatic hydrocarbon fraction the cetyl myristate and cetyl palmitate.
2. A process of claim 1 wherein said elevated temperature(s) is (are) from 65° C. to 140° C.
3. A process of claim 1 wherein the ratios of the reactants is substantially stoichiometric.
4. A process of claim 1 wherein the acid catalyst is one that will predominate in an aqueous fraction rather than that of said aromatic hydrocarbon.
5. A process of claim 4 wherein the acid catalyst will predominate almost exclusively in an aqueous fraction.
6. A process of claim 1 wherein said catalyst is phosphoric acid.
7. A process of claim 6 wherein said catalyst is 85% phosphoric acid.
8. A process of claim 1 wherein there is an aqueous fraction from which the aromatic hydrocarbon fraction is separated prior to recovering the cetyl myristate and cetyl palmitate from the aromatic hydrocarbon fraction.
9. A process of claim 8 wherein substantially all of the catalyst is retained in the aqueous fraction.
10. A process of claim 1 wherein said aromatic hydrocarbon is of the benzene series and has from six to nine carbon atoms.
11. A process of claim 9 wherein the aromatic hydrocarbon is toluene or xylene or a mixture thereof.
12. A process of claim 1 wherein the cetyl myristate comprises from about 50 to about 98% w/w of the mixture.
13. A process of claim 1 wherein the recovering of cetyl myristate and cetyl palmitate is by crystallisation and recovery from the aromatic hydrocarbon.
14. A process for preparing a mixture of cetyl myristate and cetyl palmitate, this process includes reacting cetyl alcohol with at least one fatty acid selected from group of C10-C18 fatty acids admixed with at least one aromatic hydrocarbon containing from 6 to 8 carbon atoms of the benzene series in the presence of an phosphoric acid at an elevated temperature with agitation for several hours and recovering the mixture from the aromatic liquid hydrocarbon(s).
15. A process of claim 14 wherein the agitation is from 8 to 45 hours.
16. A process of claim 14 wherein recovery is by crystallization and filtration.
17. A process of claim 14 wherein the recovery of the esters is whilst reaction continues.
18. A process for preparing cetyl myristate and cetyl palmitate when performed substantially as hereinbefore described with reference to any of the examples.
19. A mixture of cetyl myristate and cetyl palmitate produced by a process as claimed in claim 1.
20. A mixture of claim 19 wherein the cetyl myristate comprises from about 50 to about 98% w/w of the mixture.
US10/488,028 2001-08-31 2001-08-31 Synthesis of ester linked long chain alkyl moieties Expired - Fee Related US7411079B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NZ2001/000179 WO2003018731A1 (en) 1998-11-23 2001-08-31 Synthesis of ester linked long chain alkyl moieties

Publications (2)

Publication Number Publication Date
US20050033070A1 true US20050033070A1 (en) 2005-02-10
US7411079B2 US7411079B2 (en) 2008-08-12

Family

ID=32227913

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/488,028 Expired - Fee Related US7411079B2 (en) 2001-08-31 2001-08-31 Synthesis of ester linked long chain alkyl moieties

Country Status (10)

Country Link
US (1) US7411079B2 (en)
EP (1) EP1421161B1 (en)
AT (1) ATE399836T1 (en)
AU (1) AU2001290367B2 (en)
CA (1) CA2459087C (en)
CY (1) CY1109384T1 (en)
DE (1) DE60134675D1 (en)
ES (1) ES2309092T3 (en)
HK (1) HK1065815A1 (en)
WO (1) WO2003018731A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190016991A1 (en) * 2015-08-14 2019-01-17 Pharmanutra S.P.A. Cetylated fatty acids, system for the preparation thereof and use thereof

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ533370A (en) 2004-06-03 2006-11-30 Meracol Corp Ltd Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis
WO2006092605A1 (en) * 2005-03-02 2006-09-08 Croda International Plc Compounds
EP2441446A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations
EP2441441A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi A sieving method for cetyl myristate and/or cetyl palmitate
EP2441444A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
EP2583673A1 (en) 2010-10-14 2013-04-24 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2471387A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471528A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi A preparation method for suspension of cetyl myristate and/or cetyl palmitate
EP2471386A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471514A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Controlled moisture content of cetyl myristate and/or cetyl palmitate granules or formulations
EP2471384A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Suspension formulations of cetyl myristate and/or cetyl palmitate
EP2471385A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2526936B1 (en) 2011-05-23 2015-04-15 Deva Holding Anonim Sirketi Particle size distribution of cetyl myristate and/or cetyl palmitate
EP2526931B1 (en) 2011-05-23 2014-12-17 Deva Holding Anonim Sirketi Wet granulation methods of cetyl myristate and/or cetyl palmitate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049824A (en) * 1976-05-03 1977-09-20 Harry Weldon Diehl Cetyl myristoleate
US5219733A (en) * 1985-03-06 1993-06-15 Yoshikawa Oil & Fat Co., Ltd. Process for preparing fatty acid esters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756549A (en) * 1952-10-15 1956-09-05 Schou Herbert Aqueous dispersions of water-insoluble fatty acid esters
US4654207A (en) * 1985-03-13 1987-03-31 Helene Curtis Industries, Inc. Pearlescent shampoo and method for preparation of same
FR2717731B1 (en) * 1994-03-24 1996-05-15 Chryso Sa Concentrate for demolding emulsion of hydraulic binders, demolding emulsion and use.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049824A (en) * 1976-05-03 1977-09-20 Harry Weldon Diehl Cetyl myristoleate
US5219733A (en) * 1985-03-06 1993-06-15 Yoshikawa Oil & Fat Co., Ltd. Process for preparing fatty acid esters

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190016991A1 (en) * 2015-08-14 2019-01-17 Pharmanutra S.P.A. Cetylated fatty acids, system for the preparation thereof and use thereof
US10597608B2 (en) * 2015-08-14 2020-03-24 Pharmanutra S.P.A. Cetylated fatty acids, system for the preparation thereof and use thereof
US11186536B2 (en) 2015-08-14 2021-11-30 Pharmanutra S.P.A. Cetylated fatty acids, system for the preparation thereof and use thereof

Also Published As

Publication number Publication date
CA2459087A1 (en) 2003-03-06
ATE399836T1 (en) 2008-07-15
WO2003018731A1 (en) 2003-03-06
EP1421161A1 (en) 2004-05-26
CA2459087C (en) 2011-04-19
HK1065815A1 (en) 2005-03-04
CY1109384T1 (en) 2014-07-02
US7411079B2 (en) 2008-08-12
EP1421161B1 (en) 2008-07-02
DE60134675D1 (en) 2008-08-14
ES2309092T3 (en) 2008-12-16
AU2001290367B2 (en) 2008-06-19
EP1421161A4 (en) 2005-03-02

Similar Documents

Publication Publication Date Title
US7411079B2 (en) Synthesis of ester linked long chain alkyl moieties
AU2001290367A1 (en) Synthesis of ester linked long chain alkyl moieties
JPH03118355A (en) Preparation of 1-aminomethyl-1-cyclohexane acetic acid
NZ332959A (en) Preparation of cetyl myristate and cetyl palmitate
EP0044510B1 (en) Process for the preparation of diaryl esters
IE912543A1 (en) Production of acetaminophen
EP1041080B1 (en) Process for the preparation of pentaacetyl-beta-D-glucopyranose
US6278014B1 (en) Synthetic procedure for the manufacture of aspirin
JPS58105946A (en) Preparation of aminobutanol ester derivative
JPS63258832A (en) Production of dimethyl maleate
JPS5885843A (en) Preparation of succinylsuccinic diester
JPS62263195A (en) Production of pentaacetylarubutin
JPH09279179A (en) Production of fatty acid from wax ester
JPS63264491A (en) Purification of diarylalkylphosphonate reaction residue
JPS62135B2 (en)
JPS6244538B2 (en)
JPH1112208A (en) Purification of 1,3-dichloropropanol
US3248421A (en) Method of preparing 4, 4-bis (4-hydroxyaryl) pentanoic acids
JPH0273033A (en) Production of 4, 4-dimethyl-1-(p-chlorophenyl) pentane-3-one
US3948972A (en) Esterification of nitrobenzoic acids
JP2514001B2 (en) Method for producing acetin
US3221052A (en) Salicylanilide process
JPH08176042A (en) Method for simultaneously producing high-purity 2-t-butylhydroquinone and 2,5-di-t-butylhydroquinone
JPS60139636A (en) Process for producing thymol
JPS59112935A (en) Preparation of alkyl-monosubstituted hydroquinone

Legal Events

Date Code Title Description
AS Assignment

Owner name: MERACOL CORPORATION LIMITED, NEW ZEALAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JHAVERI, PARAG;REEL/FRAME:017331/0523

Effective date: 20050331

Owner name: MERACOL CORPORATION LIMITED, NEW ZEALAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CADWALLADER, DIANNE;REEL/FRAME:017331/0514

Effective date: 20040806

AS Assignment

Owner name: LYPANOSYS PTE LIMITED, SINGAPORE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LYPANOSYS LIMITED;REEL/FRAME:026883/0289

Effective date: 20100429

Owner name: LYPANOSYS LIMITED, NEW ZEALAND

Free format text: CHANGE OF NAME;ASSIGNOR:MERACOL INVESTMENTS LIMITED;REEL/FRAME:026883/0284

Effective date: 20090130

Owner name: MERACOL INVESTMENTS LIMITED, NEW ZEALAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MERACOL CORPORATION LIMITED;REEL/FRAME:026883/0278

Effective date: 20080908

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20160812